Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Safety Disclosures
Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR safety concerns, patient death, and disappointing Q3 results that triggered sharp stock declines.
SLNOsecurities fraudclass action lawsuit